BRD4 and neoplasm: While MZ-1 decreased MYC mRNA levels (Fig. 3a), it had no effect on BRD4 (Fig. 3b) or JUNB (Fig. 3c) mRNA levels in tumor cells stimulated either by adhesion to BMSCs or by IL-6.